Current Approaches To Disease Modification

Meet The Researcher Online

Dr Simon Stott introduces “disease modification” and sets out the directions the research community is taking to tackle Parkinson’s along with the related drug trials.  His presentation is followed by a Q&A Panel. The questions addressed genetic research and its applicability to the idiopathic diagnosis, the impact of Covid-19, and when new treatments could be available.

Dr. Stott is Deputy Director of Research at Cure Parkinson’s. He has been working in the field of Parkinson’s research for over 15 years in academic institutions and biotech companies. Latterly he was a research associate at the lab of Professor Roger Barker in the department of Clinical Neuroscience, University of Cambridge. Simon is also author of the  excellent blog The Science Of Parkinson’s.